Lataa...
FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
BACKGROUND: China is a highly endemic area of chronic hepatitis B (CHB). The accuracy of existed noninvasive biomarkers including TE, APRI and FIB-4 for staging fibrosis is not high enough in Chinese cohort. METHODS: Using liver biopsy as a gold standard, a novel noninvasive indicator was developed...
Tallennettuna:
| Julkaisussa: | Biomark Res |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520974/ https://ncbi.nlm.nih.gov/pubmed/33005419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00215-2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|